Lipidil Supra 160 mg (Fenofibrate TABLET) 160 MG

Lipidil Supra 160 mg tablets contain fenofibrate, a medication used to manage lipid levels. This oral tablet helps support cardiovascular health by targeting cholesterol and triglyceride levels.

Strength

160 MG

Pack Size

Manufacturer / TM Owner

BGP PHARMA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lipidil Supra 160 mg tablets are primarily used to manage lipid levels in the blood. Fenofibrate, the active ingredient, is often prescribed to help lower triglycerides and increase HDL (good cholesterol) levels. This medication is commonly used as part of a broader strategy to support heart health and manage conditions related to lipid metabolism.

Side Effects

Common effects of Lipidil Supra 160 mg tablets may include gastrointestinal discomfort, such as nausea or diarrhea. Some users might experience muscle pain or weakness. These effects vary and are not experienced by everyone who takes the medication.

Precautions & Warnings

Lipidil Supra 160 mg tablets should be handled with care. It is important to follow the advice of a healthcare provider regarding its use, especially if you have pre-existing conditions like liver or kidney disease. Always store the medication in a cool, dry place away from children.

Avoid Interactions

Lipidil Supra 160 mg tablets may interact with other medications, including blood thinners and certain cholesterol-lowering drugs. Alcohol consumption should be moderated while taking this medication. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Lipidil Supra 160 mg tablets are used to manage lipid levels, particularly to lower triglycerides and increase HDL cholesterol.

Lipidil Supra 160 mg tablets are taken orally, typically with a meal to enhance absorption. Follow the dosage instructions provided by your healthcare provider.

Common side effects may include gastrointestinal discomfort, nausea, diarrhea, and muscle pain. These effects vary among individuals.

Lipidil Supra 160 mg may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Long-term use of Lipidil Supra 160 mg should be monitored by a healthcare provider to ensure safety and effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.